The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells-Reference-Cited by-同舟云学术

The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells

Published:2018-01-05 Issue:1 Volume:19 Page:164
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Cerna Tereza,Hrabeta Jan,Eckschlager Tomas,Frei Eva,Schmeiser Heinz,Arlt Volker,Stiborová Marie

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/1/164/pdf

Reference66 articles.

1. Neuroblastoma: biological insights into a clinical enigma

2. Neuroblastoma: biology and molecular and chromosomal pathology

3. Neuroblastoma

4. Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood

5. Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bazı etanolik bitki ekstrelerinin histon deasetilaz inhibitör ve antioksidan aktiviteleri: Kanser için yeni bir terapötik yaklaşım;Cukurova Medical Journal;2023-09-30

2. Plantamajoside Alleviates Substantia Nigra Damage in Parkinson’s Disease Mice by Inhibiting HDAC2/MAPK Signaling and Reducing Microglia Polarization;ACS Chemical Neuroscience;2023-03-01

3. Ellipticine induces apoptosis and mitochondrial dysfunction in human endometriosis cell lines by activating MAPK signaling pathway;Tropical Journal of Pharmaceutical Research;2023-02-13

4. Renal protective effect of ellipticine against streptozotocin induced diabetic nephropathy in rats via suppression of oxidative stress and inflammatory mediator;Acta Cirúrgica Brasileira;2023

5. Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer;Medical Oncology;2022-09-29